NEO Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
209.3M
+3.8%
201.7M
+8.0%
186.7M
-1.8%
190.2M
+1.3%
187.8M
Cost of Revenue
112.7M
+2.6%
109.8M
+3.8%
105.8M
-1.0%
106.8M
-0.5%
107.4M
Gross Profit
96.6M
+5.1%
91.9M
+13.6%
80.9M
-3.0%
83.3M
+3.6%
80.4M
Operating Expenses
104.5M
+2.8%
101.6M
+2.6%
99.1M
+2.4%
96.8M
-10.0%
107.5M
R&D
9.9M
-8.4%
10.8M
+12.9%
9.5M
+3.9%
9.2M
+5.6%
8.7M
SG&A
94.7M
+4.2%
90.9M
+1.5%
89.6M
+3.0%
87.0M
-5.2%
91.7M
Operating Income
-7941000
+18.7%
-9771000
+46.4%
-18241000
-36.0%
-13414000
+50.3%
-27014000
EBITDA
8.2M
+28.1%
6.4M
+452.2%
-1828000
-150.7%
3.6M
+203.3%
-3491000
Net Income
-7546000
-437.2%
2.2M
+113.1%
-17106000
-73.1%
-9881000
+63.6%
-27129000
EPS (Basic)
$-0.06
-400.0%
$0.02
+115.4%
$-0.13
-62.5%
$-0.08
+61.9%
$-0.21
EPS (Diluted)
$-0.06
-400.0%
$0.02
+115.4%
$-0.13
-62.5%
$-0.08
+61.9%
$-0.21
Shares (Diluted)
128.6M
-1.7%
130.8M
+1.3%
129.2M
+0.4%
128.7M
+0.2%
128.4M
NeoGenomics (NEO) — Financials